Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress
8 months ago
By
In InvestmentsVenture Capital
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
8 months ago
By
In Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
8 months ago
By
In Biopharma HighlightsClinical TrialsInnovationInvestments
Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools
10 months ago
By
In AI & DataInvestments
Glycomine raises $115 million to push PMM2-CDG therapy into Phase 2b trial
11 months ago
By
In InvestmentsPeopleVenture Capital
Big Bets and Strategic Moves Drive Biotech Investment in 2025
11 months ago
By
In InvestmentsLeadersPartnerships
Eli Lilly’s $27 Billion Investment Highlights Surge in Biotech Funding and Strategic Partnerships
1 year ago
By
In DealsInvestmentsPeople
Takeda Seals Major $770 Million Drug Design Partnership While Other Biotech Firms Secure Vital Financing
1 year ago
By
In Funding RoundsInvestmentsPeopleVenture Capital
1 year ago
By
In InvestmentsVenture Capital
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships
1 year ago
By
In DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences
1 year ago
By
In AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Atalanta Therapeutics Secures $97M Series B to Advance RNAi Treatments for Epilepsy and Huntington’s Disease
1 year ago
By
In Clinical TrialsInvestmentsPartnershipsResearch UpdatesVenture Capital
North America Leads January Biotech Funding Round with Nearly $2 Billion Raised, Oncology and Obesity Startups Dominate
1 year ago
By
In Breaking NewsInvestmentsPartnershipsVenture Capital
Survey Reveals Clinicians Feel Ill-Prepared for Sex Differences in Disease Despite Frequent Observations
1 year ago
By
In Industry ConferencesInvestmentsPeopleTop Stories
Neumora’s Depression Drug Stumbles in Pivotal Phase 3, Stock Plummets Over 80%
1 year ago
By
In Clinical TrialsInvestmentsResearch UpdatesTop Stories
New Venture Capital Firms Step In to Fuel Clinical Research Amid Biotech Funding Shift
1 year ago
By
In Funding RoundsInvestmentsPeopleVenture Capital
Cellarity’s AI-Designed Cell Therapy Enters Phase 1 for Solid Tumors, Backed by $250M Series D
1 year ago
By
In Biopharma HighlightsClinical TrialsInvestmentsVenture Capital
Celosia Therapeutics Raises $16.75M to Advance Gene Therapy for ALS
1 year ago
By
In BreakthroughsInvestmentsPartnerships
Strand Therapeutics Raises $153M to Advance mRNA Cancer Therapies
1 year ago
By
In InvestmentsPeopleResearch Updates
AI-Powered Drug Discovery Accelerates Biopharma Innovation and Reduces R&D Costs
1 year ago
By
In Featured AnalysisInvestmentsPartnershipsResearch UpdatesTechnologyTop Stories
FDA Grants RMAT Designation to ExoGene’s Exosome-Based Gene Therapy for ALS
2 years ago
By
In FDA ApprovalsInvestmentsPharma Industry Updates